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Abstract: Previously published literature has shown a clear relationship between adverse perinatal outcome and the 
presence of maternal heart disease even when demographic and obstetric risk factors have been taken into account. 
Prospective studies from South Africa or Africa describing pregnancy outcome in mothers with heart disease, where 
there is a high prevalence of acquired rheumatic heart disease as well as cardiomyopathies and congenital heart lesions, 
are limited. Perinatal data were collected to describe the perinatal outcome in patients with heart disease. 
Objectives: The purpose of this study was to describe the perinatal outcome of pregnancies in women with heart disease 
attending a multidisciplinary clinic and to compare the perinatal mortality rate with the perinatal mortality rate for the 
background population. To determine whether there are any other associated adverse outcomes in babies born to 
mothers with heart disease. 
Methods: The first eighty-two consecutive pregnant patients with heart disease attending the weekly combined 
cardiology and obstetric clinic were studied over eighteen months. Neonatal outcome was recorded. Adverse neonatal 
outcome was defined as perinatal mortality, the need for delivery room resuscitation and admission to neonatal intensive 
care unit (NICU).  
Results: Perinatal mortality was 12.1 per 1000 live births. Only one stillbirth was documented. Adverse neonatal outcome 
was 9.7%. Caesarean section rate was 40% with 29% of infants delivered preterm.  
Conclusion: Perinatal mortality rate in this cohort was excellent - possibly due to a high level of joint care - but was linked 
to a high rate of obstetric intervention. 
Keywords: Perinatal outcome in pregnant women with heart disease in a resource limited setting. 
INTRODUCTION 
Pregnancy in the presence of maternal heart 
disease remains an important topic for interrogation 
worldwide. Although mortality from heart disease in 
pregnancy is low in absolute terms, it remains the 
leading cause of indirect maternal mortality in 
developed countries [1-7]. In South Africa, maternal 
heart disease is one of the leading causes for maternal 
mortality, prompting continuous efforts to improve 
screening, diagnosis and management of heart 
disease.  
Previously published literature has shown a clear 
relationship between adverse perinatal outcome and 
the presence of maternal heart disease even when 
demographic and obstetric risk factors have been 
accounted for [1, 3, 8, 4]. Complications in the fetus 
and neonate such as preterm delivery, respiratory  
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distress syndrome, birth asphyxia, intrauterine growth 
restriction, small for gestational age and intraventricular 
hemorrhage, occur twice as often in mothers with heart 
disease when compared to mothers without heart 
disease and the rate of occurrence of neonatal 
complications is between 17-28% [2, 4, 8]. 
The perinatal mortality rate (stillbirth and early 
neonatal death) in this group of patients is between 1-
4% in industrialized countries [3] which is significantly 
higher than in the background population (1%), and 
7.6% in sub-Saharan Africa [9]. The most significant 
cause for perinatal mortality is preterm delivery [2]. 
This correlation between maternal cardiac disease 
and adverse perinatal outcome has allowed the 
identification of predictors of adverse perinatal outcome 
which include a maternal baseline New York Heart 
Association functional class>II or cyanosis [4, 8, 10] 
maternal left heart obstruction [2, 4, 8, 11, 12] the use 
of oral anticoagulants, mechanical valve prosthesis and 
symptomatic arrhythmia [4]. 
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The potential adverse effect of maternal heart 
disease on perinatal outcome is amplified if there are 
concurrent obstetric risk factors including smoking 
during pregnancy, [4] multiple gestation or advanced 
maternal age [8].
 
Data unique to a South African setting are limited 
and the assessment of risk has been based on 
available literature from industrialized countries which 
has been extrapolated to a South African population. 
Data describing perinatal outcome in South African 
women with heart disease, where there is a high 
incidence of both acquired and congenital heart 
disease, were collected and analyzed to assess 
differences in and similarities to the described 
outcomes in an environment that is resource-depleted 
and in which there is a high prevalence of other 
medical and obstetric comorbidities.  
OBJECTIVES  
The purpose of this study was to describe the 
perinatal outcome of pregnancies in women with heart 
disease, to compare this outcome with the perinatal 
mortality rate for the background population and to 
determine whether there are any other associated 
adverse outcomes in babies born to mothers with heart 
disease.  
METHODS 
Pregnant women with cardiac disease referred to 
the weekly combined cardiology and obstetric clinic at 
Groote Schuur Hospital, Western Cape, South Africa, 
were recruited consecutively between 1 July 2010 and 
31 December 2012. The first one hundred patients 
attending the clinic were analyzed and of those eighty-
two had disease. This was a prospective study of 
consecutive patients who consented to being enrolled. 
Maternal heart disease was categorized according to 
the World Health Organization (WHO) classification of 
maternal risk as outlined in Table 1. Investigations such 
as electrocardiograms, echocardiograms, blood tests 
and fetal ultrasounds were scheduled when clinically 
indicated according to standard obstetric and 
cardiology practices. Additional interventions and/or 
monitoring were provided as indicated according to the 
nature of the cardiac disease. Spontaneous labour 
progressing to vaginal delivery was the preferred route 
of delivery. An operative delivery was deemed 
preferable in the case of certain cardiac lesions, in 
which case the mother was counseled accordingly.  
Table 1: World Health Organization Classification of 
Cardiac Diseases 
Conditions in which Pregnancy Risk is WHO I 
Uncomplicated small or mild 
  - Pulmonary stenosis 
  - Patent ductus arteriosus 
  - Mitral valve prolapse 
Successfully repaired simple lesions (arterial or ventricular septal 
defect, patent ductus arteriosus, anomalous pulmonary venous 
drainage)  
Arterial or ventricular ectopic beats, isolated 
Conditions in which Pregnancy Risk is WHO II or III 
WHO II (if otherwise well and uncomplicated)  
Unoperated atrial or ventricular septal defect 
Repaired tetralogy of Fallot 
Most arrhythmias 
WHO II-III (depending on individual)  
Mild left ventricular impairment 
Hypertrophic cardiomyopathy 
Native or tissue valvular heart disease not considered WHO I or IV 
Marfan syndrome without aortic dilatation 
Aorta < 45mm in aortic disease associated with a bicuspid valve 
Repaired Coarctation 
WHO III 
Mechanical valve  
Systemic right ventricle 
Fontan circulation 
Cyanotic heart disease (unrepaired)  
Other complex congenital heart disease  
Aortic dilatation 40-45mm in Marfan syndrome  
Aortic dilatation 45-50mm in aortic dissection with bicuspid aortic 
valve 
Conditions in which Pregnancy Risk is WHO IV (Pregnancy 
Contraindicated) 
Pulmonary arterial hypertension of any cause 
Severe systemic ventricular dysfunction (LVEF<30%, NYHA III-IV)  
Previous peripartum cardiomyopathy with any residual impairment 
of left ventricular function 
Severe mitral stenosis, severe symptomatic aortic stenosis  
Marfan syndrome with aorta dilated >45mm 
Aortic dilatation >50mm in aortic disease associated with bicuspid 
aortic valve 
Native severe Coarctation  
 
Adverse neonatal outcome was defined as stillbirth, 
early neonatal death, the requirement for delivery room 
resuscitation (bag mask ventilation and/or intubation) 
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and admission to the neonatal intensive care unit 
(NICU). 
Early neonatal death was defined as death within 
the first seven days of life. 
Preterm delivery was defined as delivery before 
thirty-seven completed weeks gestation. 
Birth asphyxia was defined as a cord pH of less 
than 7.2 at delivery or a 5-minute Apgar score of less 
than 7. 
Ethics 
Ethics approval was obtained from the University of 
Cape Town Ethics Committee. All patients provided 
written consent for inclusion in this study. 
Data Analysis 
Descriptive data were generated comparing 
adverse perinatal outcome with maternal disease, 
organized by diagnosis, severity and treatment.  
RESULTS 
Maternal Demographics and Delivery Data 
Eighty-two patients were included in the study. The 
average maternal age was twenty-seven years and the 
median parity was one. Maternal diagnoses included 
forms of both congenital and acquired cardiac disease. 
The distribution of diagnoses is listed in Table 2. 
A total of twenty-three patients had WHO class IV 
disease. The average gestational age at delivery was 
Table 2: Maternal Primary Diagnosis 
Cardiac Disease  Total  Number  Percentage 
Congenital Heart Disease 28  34 
 Uncomplicated/repaired VSD/ASD  7 8.5 
 VSD/ASD with additional abnormality  7 8.5 
 Congenital valvular heart disease  3 3.6 
 Coarctation of Aorta   4 4.8 
 Transposition of Great Arteries  1 1.2 
 Tetralogy of Fallot  3 3.6 
 Coronary/Pulmonary artery malformation  3 3.6 
Valvular Heart Disease  25  30 
 Rheumatic Valvular Heart Disease   18 21.9 
  Replaced Valves    
  Mechanical  6 7.3 
  Bioprothesis  1 1.2 
Left Ventricular Dysfunction     
 Cardiomyopathy  19  23 
  HIV  2 2.4 
  Peripartum   7 8.5 
  Hereditary   2 2.4 
  Dilated   2 2.4 
  PET/HT  6 7.3 
Other 10  12 
 Arrhythmias  6 7.3 
 Marfan Syndrome  1 1.2 
 IHD  1 1.2 
 Takayasus   1 1.2 
 Portal vein thrombosis   1 1.2 
VSD=ventricular septal defect; ASD=atrial septal defect; HIV=human immunodeficiency virus 
PET=Preeclampsia; HT= hypertension; IHD=ischemic heart disease. 
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thirty-seven weeks. Thirty-three patients were delivered 
by caesarean section and one by hysterotomy 
(termination of pregnancy for a severe fetal anomaly). 
This represents an operative delivery rate of forty-one 
percent. The caesarean sections and indications for 
operative delivery are listed in Table 3. Table 4 lists the 
cardiac indications for emergency and elective 
caesarean section. There were four operative vaginal 
deliveries (two ventous and two forceps deliveries)  
Table 3: Caesarean Section Deliveries 
Caesarean Section  Number Indication Number 
Emergency  20 Obstetric 16 
  Cardiac 4 
Elective 14 Obstetric 9 
  Cardiac 5 
 
Table 4: Cardiac Indications for Caesarean Sections 
Elective CS 
Cardiac Indication 
No. Emergency CS 
Cardiac Indication 
No 
Pulmonary arteriovenous 
malformation  
1 Mitral valve 
replacement/sepsis 
1 
Repaired Coarctation of 
aorta  
2 Pulmonary edema 1 
Cardiomyopathy  1 Eclampsia CCF and 
CMO 
1 
Mixed mitral valve disease  1 Severe MR and CCF 1 
CCF=congestive cardiac failure; CMO=cardiomyopathy MR=mitral 
regurgitation; CS=caesarean section 
Ten patients underwent induction of labour (Table 
5). Of these, seven patients were induced for maternal 
cardiac indications and three were induced for obstetric 
indications. The seven cardiac indications for induction 
of labour were based on worsening dyspnoea in six of 
the seven cases. The remaining patient had labour 
induced electively during working hours because she 
had an arrhythmia for which intra-partum external 
cardiac pacing may have been necessary. The 
induction was timed to allow access to all cardiac and 
critical care facilities.  
Table 5: Maternal Cardiac Indications for Induction of 
Labour 
Cardiac Indication Number 
Worsening dyspnoea 6 
Cardiac arrhythmia  1 
 
Perinatal Outcome 
Early Pregnancy Loss and Termination 
There was one spontaneous miscarriage and two 
terminations of pregnancy for fetal indications (a Dandy 
Walker malformation in one fetus – hysterotomy, and a 
large ventricular septal defect with overriding aorta in 
the other). 
Perinatal Mortality 
There was one stillbirth, no early neonatal deaths 
and one late neonatal death. The perinatal mortality 
rate for this study group was one out of eighty-two 
equating to 12.1 deaths per 1000 live births.  
Neonatal Data 
Seven babies met the criteria for adverse neonatal 
outcome (resuscitation at birth and admission to NICU). 
The composite adverse outcome (defined by the 
study as perinatal mortality, resuscitation at birth and 
admission to NICU) was eight out of eighty-two (9.7%).  
Stillbirth  
The stillborn infant was born at term to a mother 
with HIV-related cardiomyopathy, managed with -
blockers and diuretics. This patient had an ejection 
fraction of 54% and was on antiretroviral treatment with 
a suppressed viral load. Multiple fetal anomalies 
(hydrocephalus, macrocephaly and a cardiac lesion) 
were diagnosed by ultrasound examination and the 
patient declined a termination of pregnancy. A 
postmortem examination confirmed that the cause of 
death was due to multiple fetal anomalies and not 
attributable to any specific syndrome.  
Neonatal death  
The neonatal death occurred in an infant at one 
month of age following complications caused by 
preterm birth. This baby was delivered at thirty-four 
weeks by caesarean section because the mother had 
major placenta praevia. The patient was diabetic and 
had severe mitral regurgitation leading to an episode of 
acute cardiac failure during the antenatal period which 
required treatment with furosemide and spironolactone 
despite having an ejection fraction of 57%. The infant 
weighed 1800grams at birth and required delivery room 
resuscitation as well as NICU admission. This infant 
suffered complications related to preterm delivery 
including persistent patent ductus arteriosus, 
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intraventricular haemorrhage, sepsis, persistent 
acidosis and necrotizing enterocolitis. 
Resuscitation at Birth and Admission to NICU 
Three babies suffered birth asphyxia (one required 
intubation) and three had respiratory distress syndrome 
(Table 6). 
A total of seven infants required admission to NICU. 
Two of these seven were not included in this analysis 
because the NICU admission was for nosocomial 
sepsis (pneumonia in one and a urinary tract infection 
in the other). Four babies admitted directly after 
delivery required resuscitation at birth and 
demonstrated acidosis on cord blood gas analysis (pH 
< 7.2, Table 6). One baby was delivered at an outlying 
hospital at twenty-seven weeks gestation (weighing 
800 grams) and remained in the NICU on site. The 
details of this delivery are not known, so this baby has 
been excluded from the analysis.  
Obstetric Risk Factors and Adverse Neonatal 
Outcome 
Of the eight cases in which adverse neonatal 
outcome occurred, seven mothers suffered from one or 
more of the obstetric risk factors listed in Table 7. One 
mother had no additional risk factors. Of the seven 
mothers with obstetric risk factors, the neonatal 
outcome was influenced by the obstetric risk factor in 
four (50%) of the cases (Figure 1). 
Preterm Delivery 
Twenty-four patients (29%) delivered before thirty-
seven completed weeks gestation. Of these twenty-four 
patients, fourteen (58%) mothers went onto 
spontaneous preterm labour. Of these fourteen 
mothers, four (29%) had worsening cardiac symptoms 
prior to the onset of labour. The maternal cardiac 
diagnoses of these four mothers were history of mitral 
valve replacement and sepsis in two patients, 
cardiomyopathy and pulmonary edema in one patient 
and coarctation of the aorta with history of aortic valve 
replacement in one patient. The remaining ten patients 
were well at the onset of labour.  
Table 6: Neonates Requiring Resuscitation at Birth 
GA Cardiac Indication 
for Delivery 
Maternal Diagnosis Wt (g) Apgar 
5 Mins 
pH NICU/ 
Nursery  
Outcome 
40 No Severe MR 2845 6 7.3 Nursery Mild RDS 
34 No VSD/PDA/CoA 2260 5 7.08 NICU TTN/RDS/LBW 
37 Yes MVR and sepsis 2280 7 7.18 Nursery RDS/Sepsis 
39 No Eclampsia/abruption 
CMO 
3125 5 7.2 Nursery Birth asphyxia/RDS 
30 Yes PET induced CCF 1230 7 7.1 NICU PTD/LBW Asphyxia RDS NNJ 
40 Yes PPCMO 2880 1 6.8 NICU 
Intubated 
HIE/ asphyxia Sepsis 
34 No Severe MR 1800 9 NG NICU NND NEC Persistent Acidosis 
IVH Cardiac lesion 
GA=gestational age VSD=ventricular septal defect; PS= pulmonary stenosis; pulm=pulmonary; MR=mitral regurgitation; MMVD=mixed mitral valve disease; MVR= 
mitral valve replacement Diap=diaphragmatic hernia; PET=preeclampsia; HT= hypertension; PDA=persistent ductus arteriosus; CoA= coarctation of aorta; 
CMO=cardiomyopathy; PPCMO=peripartum cardiomyopathy. 
 
 
Perinatal Outcome in Pregnant Women with Heart Disease International Journal of Gynecology, Obstetrics and Neonatal Care, 2015, Vol. 2, No. 2    13 
Two patients were delivered preterm electively 
because of cardiac disease.  
Congenital Cardiac Disease in the Fetus 
The rate of congenital heart disease in the neonates 
was three out of eighty-two (3.7%). The stillborn baby 
had multiple fetal anomalies including a cardiac lesion, 
one pregnancy was terminated for an overriding aorta 
and a large VSD, and the baby who died at one month 
of age had a persistent PDA related to prematurity. In 
all of these cases, the mothers had acquired cardiac 
disease.  
Table 8: Neonatal Outcome and Maternal Primary 
Diagnosis 
Neonatal 
Outcome 
Number  Maternal Primary Diagnosis  
Asphyxia 3 Cardiomyopathy; PET induced cardiac 
failure; Peripartum cardiomyopathy 
Respiratory 
distress 
syndrome 
11 Mitral valve replacement; Peripartum 
cardiomyopathy Mixed mitral valve 
disease; Cardiomyopathy (2); PET 
induced cardiac failure VSD; Pulmonary 
stenosis; Coarctation of aorta; Severe 
mitral regurgitation Mitral regurgitation; 
Severe mitral regurgitation; Palpitations/ 
arrhythmia 
Requiring 
NICU 
7 Peripartum cardiomyopathy; Severe 
mitral regurgitation VSD; Mitral valve 
prolapse; PET induced cardiac failure 
Mitral regurgitation Coarctation of aorta; 
Aortic valve replacement; VSD; 
Pulmonary stenosis; Coarctation of 
aorta 
Nosocomial 
sepsis  
8 Mitral valve replacement; Peripartum 
cardiomyopathy; Severe mitral 
regurgitation VSD; Mitral valve 
prolapse; PET induced cardiac failure; 
Mitral regurgitation VSD; Pulmonary 
stenosis; Coarctation of aorta; Aberrant 
coronary artery circulation 
Requiring 
resuscitation 
13 Mitral valve replacement; Peripartum 
cardiomyopathy; Mixed mitral valve 
disease Cardiomyopathy; Severe mitral 
regurgitation (2); PET induced cardiac 
failure Acquired mitral regurgitation; 
Marfan’s syndrome; Portal vein 
thrombosis; VSD; Pulmonary stenosis; 
Coarctation of aorta; VSD; Pulmonary 
stenosis  
Weighing 
800g 
1 Coarctation of aorta; Aortic valve repair  
Preterm 
delivery  
 Pulmonary arterial hypertension; Mitral 
valve replacement (2) Severe mitral 
regurgitation (2); Repaired Tetralogy of 
Fallot; Cardiomyopathy (2); PET 
induced cardiac failure; Mitral 
regurgitation (2); Vasculitis and first 
degree heart block; Myopathic 
cardiomyopathy; VSD (2); Coarctation 
of aorta; Aortic valve replacement; 
Portal vein thrombosis; HIV 
cardiomyopathy; VSD; Pulmonary 
stenosis; Coarctation of aorta Acquired 
mitral regurgitation; Sarcoidosis and 
arrhythmias; Familial cardiomyopathy; 
Aberrant coronary artery circulation; 
VSD; Atrial fibrillation 
Congenital 
heart 
disease  
3 Severe mitral regurgitation; HIV 
cardiomyopathy; Bioprosthetic mitral 
valve 
PET=preeclampsia, VSD=ventricular septal defect; HIV=human 
immunodeficiency virus  
DISCUSSION 
The reported findings describe a uniquely African 
data set. Previously published literature describes an 
association between maternal cardiac disease and 
perinatal mortality which was not evident in this study. 
The perinatal mortality rate in this cohort was only 
1.2%. This compares favourably to the perinatal 
mortality rate for the general population from whence 
this cohort came. The perinatal mortality rate for South 
Africa was 34 per 1000 during the study period while 
Table 7: Neonatal Adverse Outcome and Associated Obstetric RIsk Factors in the 17 Pregnancies with Adverse 
Neonatal Outcome 
ORF No. of Mothers Affected No. of Neonates with NAO Secondary to ORF NAO Associated ORF 
HIV 3 None  
BMI >25  0 None  
BMI > 30  2 None  
PET 2 2 Resuscitation NICU 
DM 1 1 Resuscitation 
Medical conditions 1 None  
Placenta praevia 1 2 Resuscitation 
ORF=obstetric risk factor, NAO= neonatal adverse outcome, PTD= preterm delivery (before 37 completed weeks) BMI= body mass index, DM = diabetes mellitus, 
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perinatal mortality for the Cape Town region was 28.8 
per 1000 during the same study period. Spontaneous 
preterm delivery and prematurity related complications 
are the most common listed causes of perinatal 
mortality followed by intrapartum hypoxia, trauma, 
maternal hypertensive disorders and fetal anomalies. 
The perinatal mortality rate in this study is better than 
that reported in the literature for Africa (7.6%) [9] and is 
more in keeping with industrialized countries (1 - 4%) 
[3]. 
Nine percent of the neonates in this study suffered 
some form of adverse outcome leading to delivery 
room resuscitation or admission to NICU. This is lower 
than the previously described rate of 17-28% [2, 4, 8] of 
neonatal intervention in industrialized countries. The 
rate of obstetric intervention, that is, operative delivery 
and preterm delivery, was similarly high, but in the 
majority of cases (82%) can be ascribed to factors 
other than cardiac disease. 
In 50% of the cases where adverse neonatal 
outcome (defined as perinatal mortality, the 
requirement for delivery room resuscitation and 
admission to the NICU) was documented, additional 
obstetric risk factors necessitated obstetric intervention 
and therefore influenced the neonatal outcome.  
When the data are analyzed according to the 
cardiac disease category, the majority of the patients 
were distributed evenly between congenital heart 
disease and rheumatic heart disease. 
Maternal congenital heart disease had no effect on 
the perinatal outcome in this cohort. Of the babies 
delivered to mothers with congenital heart disease who 
had some form of adverse neonatal outcome, other 
reasons may be found to account for the adverse 
outcome, namely sepsis requiring readmission to NICU 
and spontaneous preterm labour resulting in the need 
for delivery room resuscitation.  
Maternal cardiac disease directly influenced the 
perinatal outcome in three cases from the rheumatic 
heart disease group. 
Preterm delivery is recognized as a major 
contributing factor to adverse perinatal outcome. In this 
study, the average gestational age was thirty-seven 
weeks, and 29% of patients delivered preterm. 
Although this rate of preterm delivery exceeded the 
background rate, preterm delivery in this audit was not 
a major contributing factor to adverse neonatal 
outcome. 
CONCLUSION  
The perinatal outcome in this series is better than 
that previously described for pregnancies in which 
mothers have heart disease and better than the rate for 
the general population of the Cape Town region and in 
the Republic of South Africa. This favourable outcome 
–possibly related to a high level of joint care - was 
associated with a high rate of obstetric intervention. 
Obstetric risk factors alone lead to adverse neonatal 
outcome in 50% of cases.  
This study is limited by the small sample size 
although the data are unexpectedly different to prior 
studies. A larger sample size could lead to different 
conclusions, however, neonatal outcome may also 
improve when mothers with heart disease are 
managed intensively in a multidisciplinary clinic. 
Continuous data collection and analysis would be 
helpful in assessing the degree of surveillance required 
in pregnancies complicated by maternal heart disease 
to allow the optimal outcome for both mother and 
infant.  
SYNOPSIS  
Pregnancies complicated by maternal heart disease 
managed by a combined obstetric and cardiology clinic 
in South Africa show good perinatal outcome.  
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